Skip to main content
SpringerLink
Log in

Chronische lymphatische Leukämie und Haarzellenleukämie

Diagnostik und Therapie Empfehlungen einer Konsensustagung (Berlin, 8. und 9. 2. 1996; Veranstalter: Deutsche Gesellschaft für Hämatologie und Onkologie e. V., Deutsche Krebsgesellschaft e. V. und Berliner Krebsgesellschaft e. V.)

  • Empfehlungen
  • Published:
Medizinische Klinik Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Bennett, J. M., D. Catovsky, M.-T. Daniel, G. Flandrin, D. A. G. Galton, H. R. Gralnick, C. Sultan, The French-American-British (FAB) Cooperative Group: Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J. clin. Path. 42 (1989), 567–584.

    Article  PubMed  CAS  Google Scholar 

  2. Binet, J. L., A. Auquier, G. Dighiero, C. Chastang, H. Piguet, J. Goasguen, G. Vaugier, G. Potron, P. Colona, F. Oberling, M. Thomas, G. Tchernia, C. Jacquillat, P. Boivin, C. Lesty, M. T. Duault, M. Monconduit, S. Belabbes, F. Gremy A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer (Philad.) 48 (1981), 198–206.

    Article  CAS  Google Scholar 

  3. Brittinger, G., H. Bartels, H. Common, E. Dühmke, H. H. Fülle, U. Gunzer, T. Gyenes, R. Heinz, E. König, P. Meusers, M. Paukstat, H. Pralle, H. Theml, W. Köpcke, C. Thieme, T. Zwingers, K. Musshoff, A. Stacher, H. Brücher, F. Herrmann, W. D. Ludwig, W. Pribilla, A. Burger-Schüler, G. W. Löhr, H. Gremmel, J. Oertel, H. Gerhartz, K. M. Koeppen, I. Boll, D. Huhn, T. Binder, A. Schoengen, L. Nowicki, H. W. Pees, P. G. Scheurlen, H. Leopold, M. Wannenmacher, M. Schmidt, H. Löffler, G. Michlmayr, E. Thiel, R. Zettel, U. Rühl, H. J. Wilke, E. W. Schwarze, H. Stein, A. C. Feller, K. Lennert (Kiel Lymphoma Study Group): Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas: Results of a prospective multicenter study by the Kiel Lymphoma Study Group. Hematol. Oncol. 2 (1984), 269–306.

    PubMed  CAS  Google Scholar 

  4. Cheson, B. D., J. M. Bennett, M. Grever, N. Kay, M. J. Keating, S. O’Brien, K. R. Rai: National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 87 (1996), 4990–4997.

    PubMed  CAS  Google Scholar 

  5. Dighiero, G., P. Travade, S. Chevret, P. Fenaux, C. Chastang, J. L. Binet and The French Cooperative Group on CLL: B-cell chronic lymphocytic leukemia: Present status and future directions. Blood 78 (1991), 1901–1914.

    PubMed  CAS  Google Scholar 

  6. Döhner, H., K. Fischer, M. Bentz, K. Hansen, A. Benner, G. Cabot, D. Diehl, R. Schlenk, J. Coy, S. Stilgebauer, M. Volkmann, P. R. Galle, A. Poustka, W. Hunstein, P. Lichter: p53 gene delection predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 85 (1995), 1580–1589.

    PubMed  Google Scholar 

  7. Engelhard, M., G. Brittinger, R. Heinz, H. Theml, H. Bartels, T. Binder, H. H. Fülle, H. Gerhartz, U. Gunzer, F. Ludwig, W. D. Ludwig, L. Nowicki, J. Oertel, H. W. Pees, H. Pralle, U. Rühl, Ch v. Schilling, W. Spann, A. Stacher, U. Szeimies, H. J. Wetzel, T. Zwingers, A. C. Feller, H. Stein, K. Lennert (Kiel Lymphoma Study Group, Germany and Austria): Chronic lymphocytic leukemia (B-CLL) and immunocytoma (LP-IC): Clinical and prognostic relevance of this distinction. Leuk. and Lymph. 17, Suppl. (1991), 161–173.

    Article  Google Scholar 

  8. Ezdinli, E. Z., L. Stutzman, C. W. Aungst, D. Firat: Corticosteroid therapy for lymphomas and chronic lymphocytic leukemia. Cancer (Philad.) 23 (1969), 900–909.

    Article  CAS  Google Scholar 

  9. Faguet, G. B.: Chronic lymphocytic leukemia: An updated review. J. clin. Oncol. 12 (1994), 1974–1990.

    PubMed  CAS  Google Scholar 

  10. French Cooperative Group on chronic lymphocytic leukemia. Effectiveness of „CHOP” regimen in advanced untreated chronic lymphocytic leukemia: Results from a randomized clinical trial. Lancet I (1986), 1346–1349.

    Google Scholar 

  11. French Cooperative Group on CLL, S. Johnson, A. G. Smith, H. Löffler, E. Ösby, G. Juliusson, B. Emmerich, P. J. Wyld, W. Hiddemann: Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. Lancet 347 (1996) 1432–1438.

    PubMed  CAS  Google Scholar 

  12. Hallek, M., L. Wanders, M. Ostwald, R. Busch, R. Senekowitsch, S. Stern, H. D. Schick, I. Kuhn-Hallek, B. Emmerich: Serum β2-microglobulin and serum thymidine 0 kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma. Leuk. and Lymph. 22 (1996), 439–447.

    Article  CAS  Google Scholar 

  13. Han, T., E. Z. Ezdinli, K. Shimaoka, D. V. Desai: Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia. Cancer (Philad.) 31 (1973), 502–508.

    Article  CAS  Google Scholar 

  14. Harris, N. L., E. S. Jaffe, H. Stein, P. M. Banks, J. K. C. Chan, M. L. Cleary, G. Delsol, C. De Wolf-Peeters, B. Falini, K. C. Gatter, T. M. Grogan, P. G. Isaacson, D. M. Knowles, D. Y. Mason, H. K. Müller-Hermelink, S. A. Pileri, M. A. Piris, E. Ralfkiaer, R. A. Warnke: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84 (1994) 1361–1392.

    PubMed  CAS  Google Scholar 

  15. International Workshop on Chronic Lymphocytic Leukemia: Chronic lymphocytic leukemia: Recommendations for diagnosis, staging, and response criteria. Ann. intern. Med. 110 (1989), 236–238.

    Google Scholar 

  16. Jaksic, B., M. Brugiatelli, I. Krc, H. Losonczi, J. Holowiecki, B. Labar, V. Jacopino, D. Lutz: Comparison of high-dose chlorambucil versus Binet’s modified CHOP regimen in B-cell chronic lymphocytic leukemia in advanced phase: Results of an international multicentric randomized trial. Blood 86 Suppl. 1 (1995, 607a.

    Google Scholar 

  17. Keating, M. J., H. Kantarjian, M. Talpaz, J. Redman, C. Koller, B. Barlogie, W. Velasquez, W. Plunkett, E. J. Freireich, K. B. McCredie: Fludarabine — a new agent with major activity against chronic lymphocytic leukemia. Blood 74 (1989), 19–25.

    PubMed  CAS  Google Scholar 

  18. Knospe, W. H., V. Loeb jr., C. M. Huguley jr.: Biweekly chlorambucil treatment of chronic lymphocytic leukemia. Cancer (Philad.) 33 (1974), 555–562.

    Article  CAS  Google Scholar 

  19. Michallet, M., E. Archimbaud, G. Bandini, P. A. Rowlings, H. J. Deeg, G. Gahrton, E. Monteerrat, C. Rozman, A. Gratwohl, P. Gale: HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. Ann. intern. Med. 124 (1996), 311–315.

    PubMed  CAS  Google Scholar 

  20. Montserrat, E., A. Alcalá, C. Alonso, J. Besalduch, J. M. Moraleda, J. García-Conde, M. Gutierrez, F. Gomis, J. Garijo, M. C. Guzmán, J. Estapé, C. Rozman and participating members of Pethema, Spanish Society of Hematology: A randomized trial comparing chlorambucil plus prednisone vs. cyclophosphamide, melphalan, and prednisone in the treatment of chronic lymphocytic leukemia stages B and C. Nouv. Rev. franç. Hémat. 30 (1988), 429–432.

    CAS  Google Scholar 

  21. Montserrat, E., A. Alcalá, R. Parody, A. Domingo, J. García-Conde, J. Bueno, C. Ferrán, M. A. Sanz, M. Giralt, D. Rubio, I. Antón, J. Estapé, C. Rozman and participating members of Pethema; Spanish Cooperative Group for Hematological Malignancies Treatment, Spanish Society of Hematology: Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone. Cancer (Philad.) 56 (1985), 2369–2375.

    Article  CAS  Google Scholar 

  22. Montserrat, E., C. Rozman: Chronic lymphocytic leukemia: Present status. Ann. Oncol. 6 (1995) 219–235.

    PubMed  CAS  Google Scholar 

  23. O’Brien, S., A. del Giglio, M. Keating: Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood 85 (1995), 307–318.

    PubMed  Google Scholar 

  24. Provan, D., L. Bartlett-Pandite, C. Zwicky, D. Neuberg, A. Maddocks, P. Corradini, R. Soiffer, J. Ritz, L. M. Nadler, J. G. Gribben: Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood 88 (1996), 2228–2235.

    PubMed  CAS  Google Scholar 

  25. Rai, K. R., A. Sawitsky, E. P. Cronkite, A. D. Chanana, R. N. Levy, B. S. Pasternack: Clinical staging of chronic lymphocytic leukemia. Blood 46 (1975), 219–234.

    PubMed  CAS  Google Scholar 

  26. Raphael, B., J. W. Anderson, R. Silber, M. Oken, D. Moore, J. Bennett, H. Bonner, R. Hahn, W. H. Knospe, J. Mazza, J. Glick: Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: Long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical. J. clin. Oncol. 9 (1991), 770–776.

    PubMed  CAS  Google Scholar 

  27. Rozman, C., E. Montserrat: Chronic lymphocytic leukemia. New Engl. J. Med. 333 (1995), 1052–1057.

    Article  PubMed  CAS  Google Scholar 

  28. Sawitsky, A., K. R. Rai, O. Glidewell, R. T. Silver and participating members of CALGB (Cancer and Leukemia Group B): Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia. Blood 50 (1977), 1049–1059.

    PubMed  CAS  Google Scholar 

  29. Tallman, M. S., D. Hakimian: Purine nucleoside analogs: Emerging roles in indolent lymphoproliferative disorders. Blood 86 (1995), 2463–2474.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. II. Innere Klinik, Krankenhaus Moabit, Turmstra\e 21, D-10559, Berlin

    Günter Brittinger, Klaus -Peter Hellriegel & Wolfgang Hiddemann

Authors
  1. Günter Brittinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Klaus -Peter Hellriegel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wolfgang Hiddemann
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Teilnehmer der Konferenz: M. Bentz, Heidelberg · L. Bergmann, Frankfurt · P. Borchmann, Köln · V. Budach, Berlin · B. Dörken, Berlin · B. Emmerich, München · J. Finke, Freiburg · H. H. Fülle, Berlin · W. Gaßmann, Kiel · M. Hallek, München · H. Heimpel, Ulm · R. Heinz, Wien · J. Hense, Essen · H. Huber, Wien · D. Huhn, Berlin · U. Jäger, Wien · W. U. Knauf, Berlin · M. Kneba, Göttingen · R. Kuse, Hamburg · W. D. Ludwig, Berlin · P. Meusers, Essen · G. Ott, Würzburg · C. Peschel, Mainz · H. Pralle, Gießen · H. Rückle, Würzburg · N. Schmitz, Kiel · W. Schneider, Düsseldorf · H. Stein, Berlin · L. Trümper, Homburg · M. Wilhelm, Würzburg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brittinger, G., Hellriegel, K.P. & Hiddemann, W. Chronische lymphatische Leukämie und Haarzellenleukämie. Med Klin 92, 309–312 (1997). https://doi.org/10.1007/BF03044768

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03044768

Search

Navigation